Similar Posts
Sarepta Therapeutics Stock Soars on FDA Approval
SRPT Sarepta Therapeutics $160.72 +37.22 (+30.14%) (As of 05:50 PM ET) 52-Week Range $55.25 ▼ $173.25 P/E Ratio 1,461.09 Price Target $177.65 Sarepta Therapeutics NASDAQ: SRPT is leading the game in precision genetic medicine and biotechnology. Sarepta Therapeutics’ stock price has witnessed a surge of over 40% after receiving expanded FDA approval for its Duchenne muscular…
Bunge charters first Argentine soy meal cargo to China
Bunge charters first Argentine soy meal cargo to China Source link
Replimmune: Continuing To Justify The Bear Thesis (For Now) (NASDAQ:REPL)
ImagineGolf/E+ via Getty Images Before we begin, I just want to remind you that I have prepared an article on ASCO and the various biotechnology companies that are showing up, you can read that here. There are over 50 companies being represented in the oral sessions, so click here to read more on what will…
Ollie’s Bargain Outlet Stock Won’t be a Bargain Much Longer
Shares of Ollie’s Bargain Outlet NASDAQ: OLLI are heading higher following the Q1 release and will likely continue rallying this year because of its market-leading growth. The company is a growing opportunity in off-price retail, outpacing the industry trend. The latest report includes outperformance, increased guidance, and an improved long-term target that suggests the rally…
